BAC
50
-6
SJM
33
14
SPG
56
-7
GIS
37
2
AFL
49
-3
DHR
50
7
LYB
41
-3
VTR
47
-3
CTAS
56
-5
HUM
43
-5
MPC
44
3
BRK.B
43
-2
PWR
71
-3
CPB
39
2
EFX
41
-3
IPG
57
-2
CME
62
-3
PPL
52
-7
KEY
40
-3
GWW
67
-4
BAC
50
-6
SJM
33
14
SPG
56
-7
GIS
37
2
AFL
49
-3
DHR
50
7
LYB
41
-3
VTR
47
-3
CTAS
56
-5
HUM
43
-5
MPC
44
3
BRK.B
43
-2
PWR
71
-3
CPB
39
2
EFX
41
-3
IPG
57
-2
CME
62
-3
PPL
52
-7
KEY
40
-3
GWW
67
-4
Financhill
Back

Avalon Globocare Vs. NovoCure Industry Stock Comparison

Sell
48

ALBT
Avalon Globocare

Last Price:
2.43
Seasonality Move:
-10.73%
Buy
82

NVCR
NovoCure

Last Price:
30.52
Seasonality Move:
2.04%
Sell
48
Avalon Globocare (ALBT) is a Sell

Is Avalon Globocare a Buy, Sell or Hold?

  • The current Avalon Globocare [ALBT] share price is $2.45. The Score for ALBT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ALBT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $29.85. The Score for NVCR is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

ALBT Stock Price Chart

What is Avalon Globocare's stock price today?

  • The Avalon Globocare share price today is $2.45
    The current trend is moderately bearish and ALBT is experiencing selling pressure, which indicates risk of future bearish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $29.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight buying pressure.

ALBT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.24 Buy
Relative Strength Index (14 RSI): 41.14 Sell
Chaikin Money Flow: -40408 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.59 - 3.43) Sell
Bollinger Bands (100): (-0.23 - 2.17) Buy

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.5 Buy
Relative Strength Index (14 RSI): 83.96 Buy
Chaikin Money Flow: 5788123 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.1 - 20.5) Buy
Bollinger Bands (100): (15.67 - 19.79) Buy

ALBT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.68 Sell
20-day SMA: 2.92 Sell
50-day SMA: 1.61 Buy
200-day SMA: 0.67 Buy
8-day EMA: 2.7 Sell
20-day EMA: 2.62 Sell
50-day EMA: 1.95 Buy
200-day EMA: 1.03 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.74 Buy
20-day SMA: 18.16 Buy
50-day SMA: 16.86 Buy
200-day SMA: 17.27 Buy
8-day EMA: 20.98 Buy
20-day EMA: 18.81 Buy
50-day EMA: 17.73 Buy
200-day EMA: 18.95 Buy

Avalon Globocare Earnings Growth & ALBT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

Avalon Globocare Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):